Correction to: Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicenter Spanish study (European Journal of Pediatrics, (2021), 180, 9, (3029-3038), 10.1007/s00431-021-04063-6)

1. Garcia-Romero, R.
2. de Zabarte Fernandez, J.M.M.
3. Pujol-Muncunill, G.
4. Donat-Aliaga, E.
5. Segarra-Cantón, O.
6. Irastorza-Terradillos, I.
7. Medina-Benitez, E.
8. Ruiz-Hernández, C.J.
9. Carrillo-Palau, M.
10. Ros-Arnal, I.
11. Rodriguez-Martínez, A.
12. Escartin-Madurga, L.
13. Gutiérrez-Junquera, C.
14. Vicente-Santamaría, S.
15. Rodriguez-Belvis, M.V.
16. Fernández-Fernández, S.
17. Alberto-Alonso, J.R.
18. Montraveta, M.
19. Torres-Peral, R.
20. Navalon-Rubio, M.
21. Navas-López, V.M.
22. de Carpi, J.M.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1007/S00431-021-04117-9 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

•